-
U.S. Department of Energy Awards Metabolix $6 Million Grant to Develop Renewable Biofuels
Monday, May 16, 2011 - 4:02pm | 196Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on developing clean, sustainable solutions for plastics, chemicals and energy, today announced that the U.S. Department of Energy has awarded the company a $6 million grant. The grant is part of the Obama administration's $42 million...
-
Top Percentage Gainers and Losers as of 2:15pm 5/16/2011 (VITA, SYK, CISG, TISA, ENOC, TSTC, SPMD, KNDI, ABIO, KONG, OXGN, VRML, PSTR, FXCM, ATRN, SYMX, GSL)
Monday, May 16, 2011 - 2:15pm | 627Best 1) Orthovita (NASDAQ: VITA): Trading up 40.1% from Friday's close to $3.82. Orthovita is set to be acquired by Stryker (NYSE: SYK) for $3.85 per share in cash. The deal is valued at $316 million. 2) CNinsure (NASDAQ: CISG): Trading up 30.3% from Friday's close to $17.15. CNinsure received an...
-
Eli Lilly Provides Its Perspective in Response to Amylin Lawsuit
Monday, May 16, 2011 - 2:11pm | 399Eli Lilly and Company (NYSE: LLY) has provided additional perspective in response to Amylin Pharmaceuticals, Inc.'s (NASDAQ: AMLN) lawsuit filed in the United States District Court for the Southern District of California. The lawsuit alleges that Lilly is not using commercially reasonable efforts...
-
Calls Purchased on Oncothyreon Inc. (ONTY)
Monday, May 16, 2011 - 11:53am | 107Shares of Oncothyreon Inc. (NASDAQ: ONTY) are lower on the session by 2.37%, currently trading at $5.77. The stock has been moving largely higher over the past four months, though it is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name...
-
Options Brief: Cytori Therapeutics (CYTX)
Monday, May 16, 2011 - 11:04am | 69Shares of Cytori Therapeutics (NASDAQ: CYTX) are lower on the session by 4.77%, trading at $5.79. Overall put volume is now running at 3.83x the daily average, with 45% of all puts traded being purchases on the offer. 1,160 contracts have traded on the session so far. Cytori Therapeutics, Inc....
-
Benzinga's Volume Movers (CISG, SIGA, NDAQ, ENOC)
Monday, May 16, 2011 - 10:32am | 190CNinsure Inc (NASDAQ: CISG) shares moved up 29.94% to $17.10 at 10:30 am. The volume of CISG shares traded was 1031% higher than normal. CISG's Board of Directors received a preliminary non-binding going private proposal. SIGA Technologies Inc (NASDAQ: SIGA) shares rose 5.00% to $14.90. The volume...
-
NASDAQ Stocks Hitting 52-Week Highs (TISA, VITA, ORCH, IPSU)
Monday, May 16, 2011 - 10:22am | 153Top Image Systems Ltd (NASDAQ: TISA) shares surged 33.17% to create a new 52-week high of $2.73. TISA reported that it has launched mobile banking solutions. Orthovita Inc (NASDAQ: VITA) shares jumped 40.11% to create a new 52-week high of $3.83. VITA agreed to be purchased by Stryker Corp (NYSE:...
-
Options Brief: SIGA Technologies, Inc. (SIGA)
Monday, May 16, 2011 - 10:20am | 92Shares of SIGA Technologies, Inc.. (NASDAQ: SIGA) are higher on the session by 4.16%, trading at $14.78. Overall call volume is now running at 2.38x the daily average, with 19% of all calls traded being purchases on the offer. 2,596 contracts have traded on the session so far. SIGA Technologies...
-
Lilly Provides Statement in Response to Amylin Lawsuit
Monday, May 16, 2011 - 9:54am | 197Eli Lilly and Company (NYSE: LLY) has provided the following statement in response to a lawsuit and motion for temporary restraining order filed by Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) against Lilly. The action was filed in the United States District Court for the Southern District of...
-
Cleveland BioLabs Announces New US Patent Allowances for CBLB502 and CBLB612
Monday, May 16, 2011 - 9:01am | 116Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its Protectan CBLB502 U.S. Patent Application Number 11/722,682, titled "Flagellin Related Polypeptides and Uses Thereof." Allowed claims cover composition...
-
Morgan Stanley Maintains Underweight on Vertex Pharmaceuticals (VRTX)
Monday, May 16, 2011 - 8:35am | 115Morgan Stanley is out with its report today on Vertex Pharmaceuticals (NASDAQ: VRTX), maintaining Underweight. In a note to clients, Morgan Stanley writes, "Merck's boceprevir received FDA approval Friday, roughly on schedule but ahead of the expectations of more bullish Vertex investors who...
-
Most Popular Stocks Right Now on 5/16/11- CNOZ, MBYL, ALKS, BAC, DANR, PRM, HPNN, LOW, BRP, PSP, WNWG
Monday, May 16, 2011 - 8:29am | 1233Cono Italiano Inc. (CNOZ) is trading at a price of $0.0250, a dramatic change of +0.0050 with % change of 25.00% from its previous day's close. Currently, the company has a Market capitalization (total value of a company in the stock market) of approximately 2.30M Mobile Data Corp (MBYL) is...
-
J.P. Morgan Reiterates Neutral on Vertex Pharmaceuticals (VRTX)
Monday, May 16, 2011 - 7:43am | 230J.P. Morgan is out with its report today on Vertex Pharmaceuticals (NASDAQ: VRTX), reiterating Neutral. In a note to clients, J.P. Morgan writes, "VRTX shares are up 20% since FDA briefing documents were released for telaprevir in late April; this was driven by expectations that approval of...
-
Piper Jaffray Reiterates Overweight on Vertex Pharmaceuticals (VRTX)
Monday, May 16, 2011 - 7:26am | 151Piper Jaffray is out with its report on Vertex Pharmaceuticals (NASDAQ: VRTX), maintaining Overweight. In a note to clients, Piper Jaffray writes, "On Friday 5/13, Merck received approval for VICTRELIS in combination with peginterferon alfa and ribavirin for the treatment of chronic HCV genotype 1...
-
Intermune Announces Presentation Of Positive Pirfenidone Data At The International Conference Of The American Thoracic Society
Monday, May 16, 2011 - 7:20am | 194InterMune, Inc. (Nasdaq: ITMN) today announced that an oral presentation and a poster presentation related to the company's development program for pirfenidone in idiopathic pulmonary fibrosis will be presented at the 2011 International Conference of the American Thoracic Society, being held in...